Are we able to prevent invasive meningococcal disease in Brazil?
DOI:
https://doi.org/10.33448/rsd-v11i11.33824Keywords:
National immunization program; Health; Infectious disease.Abstract
Background: Invasive meningococcal disease (IMD) remains a major public health problem associated with death and severe consequences, especially in children. However, IMD is preventable through vaccination, with vaccines available to cover five of the six most common disease-causing strains (A, B, C, X, Y, and W). Surveillance systems are necessary for monitoring IMD incidence, together with the severity and serogroup prevalence of the disease. knowledge of the prevalence of Neisseria meningitidis (Nm) serogroups in IMD is critical for adopting the best strategies for meningococcal immunization. Method: In Brazil, all IMD cases are reported to the National Disease Notification System (SINAN). The goal of this study is to evaluate the epidemiological and microbiological data retrieved from SINAN from 2007–19. Results: During this period, 251,773 cases were reported with around 9% of them progressing to death. Furthermore, in approximately 95% of cases, the serogroup was not identified. Conclusions: Hence, improving the SINAN information is crucial for guiding future IMD prevention, such as vaccination and control strategies.
References
Andrade, A. L., Minamisava, R., Tomich, L. M., Lemos, A. P., Gorla, M. C., de Cunto Brandileone, M. C., . . . Meningococcal Study, G. (2017). Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil. Vaccine, 35(16), 2025-2033. doi: 10.1016/j.vaccine.2017.03.010
Chicuto, L. A. D., de Moraes, C., Cassio de Moraes, J., & Safadi, M. A. P. (2020). A critical analysis of serogroup B meningococcal disease burden in Brazil (2001-2015): implications for public health decisions. Hum Vaccin Immunother, 1-6. doi: 10.1080/21645515.2019.1700710
Cordeiro, S. M., Neves, A. B., Ribeiro, C. T., Petersen, M. L., Gouveia, E. L., Ribeiro, G. S., . . . Ko, A. I. (2007). Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil. Trans R Soc Trop Med Hyg, 101(11), 1147-1153. doi: 10.1016/j.trstmh.2007.06.012
Galvao, P. R., Ferreira, A. T., Maciel, M. D., De Almeida, R. P., Hinders, D., Schreuder, P. A., & Kerr-Pontes, L. R. (2008). An evaluation of the Sinan health information system as used by the Hansen's disease control programme, Pernambuco State, Brazil. Lepr Rev, 79(2), 171-182.
Ibarz-Pavon, A. B., Lemos, A. P., Gorla, M. C., Regueira, M., Sireva Working Group, I., & Gabastou, J. M. (2012). Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010. PLoS One, 7(8), e44102. doi: 10.1371/journal.pone.0044102
Moraes, C., Moraes, J. C., Silva, G. D., & Duarte, E. C. (2017). Evaluation of the impact of serogroup C meningococcal disease vaccination program in Brazil and its regions: a population-based study, 2001-2013. Mem Inst Oswaldo Cruz, 112(4), 237-246. doi: 10.1590/0074-02760160173
Morello, B. R., Milazzo, A., Marshall, H. S., & Giles, L. C. (2021). Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease. J Infect Public Health, 14(8), 1069-1074. doi: 10.1016/j.jiph.2021.06.014
Moura Silveira, M., McBride, A. J. A., & Trotter, C. L. (2019). Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme. Vaccine, 37(45), 6783-6786. doi: 10.1016/j.vaccine.2019.09.062
Nunes, A. M., Ribeiro, G. S., Ferreira, I. E., Moura, A. R., Felzemburgh, R. D., de Lemos, A. P., . . . Campos, L. C. (2016). Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil. PLoS One, 11(11), e0166475. doi: 10.1371/journal.pone.0166475
Presa, J., Serra, L., Weil-Olivier, C., & York, L. (2022). Preventing invasive meningococcal disease in early infancy. Hum Vaccin Immunother, 18(5), 1979846. doi: 10.1080/21645515.2021.1979846
Presa, J. V., de Almeida, R. S., Spinardi, J. R., & Cane, A. (2019). Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis. Int J Infect Dis, 80, 137-146. doi: 10.1016/j.ijid.2019.01.009
Safadi, M. A., Berezin, E. N., & Arlant, L. H. (2014). Meningococcal Disease: Epidemiology and Early Effects of Immunization Programs. J Pediatric Infect Dis Soc, 3(2), 91-93. doi: 10.1093/jpids/piu027
Safadi, M. A., O'Ryan, M., Valenzuela Bravo, M. T., Brandileone, M. C., Gorla, M. C., de Lemos, A. P., . . . Global Meningococcal, I. (2015). The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations. Vaccine, 33(48), 6529-6536. doi: 10.1016/j.vaccine.2015.10.055
Safadi, M. A. P., Valenzuela, M. T., Carvalho, A. F., De Oliveira, L. H., Salisbury, D. M., & Andrus, J. K. (2017). Knowing the scope of meningococcal disease in Latin America. Rev Panam Salud Publica, 41, e118. doi: 10.26633/RPSP.2017.118
Serra, L., Presa, J., Christensen, H., & Trotter, C. (2020). Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the Literature. Infect Dis Ther, 9(2), 209-240. doi: 10.1007/s40121-020-00291-9
Sheerin, D., Openshaw, P. J., & Pollard, A. J. (2017). Issues in vaccinology: Present challenges and future directions. Eur J Immunol, 47(12), 2017-2025. doi: 10.1002/eji.201746942
Silveira, M. M., Conrad, N. L., & Leivas Leite, F. P. (2021). Effect of COVID-19 on vaccination coverage in Brazil. J Med Microbiol, 70(11). doi: 10.1099/jmm.0.001466
Tauil Mde, C., Carvalho, C. S., Vieira, A. C., & Waldman, E. A. (2014). Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil. Braz J Infect Dis, 18(4), 379-386. doi: 10.1016/j.bjid.2013.11.012
Trotter, C. L., & Maiden, M. C. (2009). Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines, 8(7), 851-861. doi: 10.1586/erv.09.48
Xu, J., Chen, Y., Yue, M., Yu, J., Han, F., Xu, L., & Shao, Z. (2022). Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis. Hum Vaccin Immunother, 2071077. doi: 10.1080/21645515.2022.2071077
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marcelle Moura Silveira; Neida Lucia Conrad; Thaís Larré Oliveira; Daiane Drawanz Hartwig
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
